HEK293 cells expressing hHCN1 were characterised in terms of their biophysical and pharmacological properties using whole-cell patch clamp techniques and IonWorksTM HT electrophysiology. The biophysical properties are typical of hHCN1 both in terms of V½ of activation (-86 ± 3 mV, n=11) and the time course of activation (e.g. 349 ± 130 ms at -110 mV and 104 ± 32 ms at -140 mV, n=6). Under whole-cell recording conditions the mean current amplitude was 2.7 ± 0.5 nA at -130 mV (n =10) and reversal potential measurements indicated permeability to both Na+ and K+ (PNa/PK around 0.2) typical of HCN channels.
Currents were dose-dependently inhibited by the selective HCN blocker ZD7288 (IC50 value of 44 µM) and the inorganic cation Caesium (Cs+, IC50 value of 114 µM) in line with reported literature values. The currents were also insensitive (<10% inhibition) to the tyrosine kinase inhibitor genistein (100 µM) although the same concentration markedly inhibited hHCN2 currents (approximately 66% inhibition, Millipore PrecisIONTM HCN2-HEK293 recombinant cell line, CYL3041). These differences in sensitivity have been noted by others and support the notion that this cell line selectively expresses hHCN1 channels. Channel expression, monitored using IonWorksTM HT, is robust over at least 40 passages. For example 76% of cells expressed outward current >500 pA at passage 40 (n=123) with a mean current amplitude of 1.41 nA.